European Journal of Cancer
Volume 45, Issue 18 , Pages 3149-3155, December 2009

The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen

  • Evangelos Chandanos

      Affiliations

    • Corresponding Author InformationCorresponding author: Address: Norra Stationsgatan 67, II Karolinska Institutet, SE-171 76 Stockholm, Sweden. Tel.: +46 8 517709 57; fax: +46 8 33 15 87.
  • ,
  • Jesper Lagergren

Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 76 Stockholm, Sweden

Received 30 May 2009; received in revised form 24 August 2009; accepted 2 September 2009. published online 05 October 2009.

Abstract 

Oesophageal cancer is the sixth most common form of cancer death globally with almost 400,000 deaths annually. More than 90% of all cases are either adenocarcinomas (OAC) or squamous-cell carcinomas (OSCC). There is a strong male predominance with up to 8 and 3 men for every woman affected with OAC and OSCC, respectively. It has been hypothesised that sex hormonal factors may play a role in the development of oesophageal cancer or more specifically that oestrogen prevents such development. This article reviews the available literature on this topic. Basic science studies suggest an inhibitory effect of oestrogen in the growth of oesophageal cancer cells, and a possible mechanism of any oestrogen protection might be mediated through oestrogen receptors. But from the few epidemiological studies in which the hypothesis of oestrogen protection has been tested, no firm conclusions can yet be drawn of the role of oestrogen in human oesophageal cancer aetiology. More evidence from valid and large human studies is needed before any conclusions can be drawn.

Keywords: Oestrogen, Adenocarcinoma, Squamous-cell carcinoma, Receptor, Neoplasm, Sex hormone

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(09)00673-X

doi:10.1016/j.ejca.2009.09.001

European Journal of Cancer
Volume 45, Issue 18 , Pages 3149-3155, December 2009